Audit 39460

FY End
2022-12-31
Total Expended
$6.94M
Findings
0
Programs
24
Year: 2022 Accepted: 2023-09-28
Auditor: Kpmg LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.498 Provider Relief Fund $3.03M Yes 0
16.758 Improving the Investigation and Prosecution of Child Abuse and the Regional and Local Children's Advocacy Centers $1.42M - 0
97.036 Disaster Grants - Public Assistance (presidentially Declared Disasters) $498,825 - 0
93.394 Cancer Detection and Diagnosis Research $343,777 Yes 0
93.395 Cancer Treatment Research $271,250 Yes 0
93.153 Coordinated Services and Access to Research for Women, Infants, Children, and Youth $255,861 - 0
93.310 Trans-Nih Research Support $188,769 Yes 0
93.127 Emergency Medical Services for Children $109,256 - 0
93.889 National Bioterrorism Hospital Preparedness Program $96,222 - 0
16.575 Crime Victim Assistance $53,955 - 0
93.365 Sickle Cell Treatment Demonstration Program $46,137 Yes 0
93.917 Hiv Care Formula Grants $40,127 - 0
93.865 Child Health and Human Development Extramural Research $40,000 Yes 0
93.855 Allergy, Immunology and Transplantation Research $36,902 Yes 0
16.543 Missing Children's Assistance $26,976 - 0
93.940 Hiv Prevention Activities_health Department Based $24,832 - 0
93.080 Blood Disorder Program: Prevention, Surveillance, and Research $24,630 - 0
93.914 Hiv Emergency Relief Project Grants $17,517 - 0
93.837 Cardiovascular Diseases Research $17,050 Yes 0
93.317 Emerging Infections Programs $16,476 - 0
93.110 Maternal and Child Health Federal Consolidated Programs $6,609 - 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $5,881 Yes 0
93.350 National Center for Advancing Translational Sciences $2,950 Yes 0
93.838 Lung Diseases Research $1,800 Yes 0

Contacts

Name Title Type
JR53UMNS5Y87 Brenda McCormick Auditee
9529308700 Andrew Lanik Auditor
No contacts on file

Notes to SEFA

Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (the Schedule) summarizes the expenditures of Childrens Health Care and its subsidiaries (Childrens) under programs of the U.S. government for the year ended December 31, 2022. For purposes of the Schedule, federal awards include all grants, contracts, and similar agreements entered into directly between Childrens and agencies and departments of the federal government and all subawards made to Childrens by nonfederal organizations pursuant to federal grants, contracts, and similar agreements. The awards are classified into program categories in accordance with the provisions of the Uniform Guidance. For the year ended December 31, 2022, Childrens had no expenditures in the form of noncash assistance, had no federally provided insurance in effect, or loans or loan guarantees outstanding at year end. This Schedule is presented using the accrual basis of accounting. The information in this schedule is presented in accordance with the requirements of the Uniform Guidance. De Minimis Rate Used: N Rate Explanation: Expenditures for federal programs are recognized using cost accounting principles contained in the Uniform Guidance, Cost Principles for Non Profit Organizations (2 CFR part 230). Under these cost principles, certain types of expenditures are not allowed or are limited as to reimbursement. Expenditures include a portion of costs associated with general activities (facilities and administrative costs or indirect costs), which are allocated to federal awards under negotiated formulas. Indirect costs allocated to such awards for the year ended December 31, 2022 were based on a predetermined rate of 60.7% negotiated with Childrens oversight federal agency, the U.S. Department of Justice, and are included as a component of the expenditures for applicable grants in the Schedule. Lower facilities and administrative cost rates were used when specifically stated in respective grant agreements. Subsequent to year-end, Childrens received a provisional fixed indirect cost rate agreement dated April 14, 2023, that has been negotiated with the U.S. Department of Justice, and is effective through December 31, 2023.